Learn About Acquired Agranulocytosis

What is the definition of Acquired Agranulocytosis?
Acquired agranulocytosis is a rare disorder characterized by a severe decrease in white blood cells (granulocytes) and is usually caused by drugs used to treat cancer, such as chemotherapy, and antipsychotic medications, such as clozapine, which interfere with the production of granulocytes in the bone marrow. The decrease in granulocytes makes individuals with acquired agranulocytosis more susceptible to bacteria infections from bacteria that would otherwise not be considered harmful in a healthy individual.
Save information for later
Sign Up
What are the symptoms of Acquired Agranulocytosis?
Early symptoms of acquired agranulocytosis are usually a bacterial infection that may include weakness, extreme fatigue, fever, chills, and infected ulcerations in the mucous membranes of the mouth, throat, and intestinal tract, along with difficulty swallowing (dysphagia) and irritation, pain, and swelling due to the ulcers. As the reduction in granulocytes (granulocytopenia) continues, patients with acquired agranulocytosis may develop an enlarged spleen (splenomegaly) and neutropenia (decreased blood neutrophils). In addition to the early symptoms, individuals with chronic acquired agranulocytosis may experience the development of canker sores in the mouth and gingivitis (inflammation of the gums) that regularly recurs.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Acquired Agranulocytosis?
The standard treatment for acquired agranulocytosis is the drug, filgrastim (Neupogen), in addition to identifying and discontinuing other drugs that may be causing the disorder. Some patients with acquired agranulocytosis may require treatment with antibiotics or corticosteroid therapy for associated bacterial infections. Immunocompromised patients with acquire agranulocytosis may require gamma globulin infusions. The associated mouth and throat ulcers can be treated with saline or hydrogen peroxide gargles, anesthetic lozenges, and antifungal mouthwashes containing the drug, nystatin, for oral fungal infections, such as thrush or Candida albicans (yeast infection). A liquid diet may be necessary until the ulcers heal. Acquired agranulocytosis will usually resolve once the granulocyte levels return to normal.
Who are the top Acquired Agranulocytosis Local Doctors?
Elite
Highly rated in
12
conditions
Oncology
Hematology Oncology

SCCA Outpatient Clinic At South Lake Union

825 Eastlake Ave E 
Seattle, WA 98109

Gary Lyman is an Oncologist and a Hematologist Oncology doctor in Seattle, Washington. Dr. Lyman has been practicing medicine for over 50 years and is rated as an Elite doctor by MediFind in the treatment of Acquired Agranulocytosis. He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Febrile Neutropenia, Agranulocytosis, Venous Thromboembolism, and Acquired Agranulocytosis. He is licensed to treat patients in Washington. Dr. Lyman is currently accepting new patients.

Elite
Highly rated in
9
conditions

Clinique De Genolier

Oncology Department, Genolier Cancer Center 
Genolier, VD, CH 

Matti Aapro is in Genolier, Switzerland. Aapro is rated as an Elite expert by MediFind in the treatment of Acquired Agranulocytosis. They are also highly rated in 9 other conditions, according to our data. Their top areas of expertise are Febrile Neutropenia, Acquired Agranulocytosis, Agranulocytosis, and Breast Cancer.

 
 
 
 
Learn about our expert tiers
Learn more
Distinguished
Highly rated in
9
conditions

University Of Ulsan

Department Of Internal Medicine, Kyunghee University 
Seoul, KR 

Shin Ahn is in Seoul, Republic of Korea. Ahn is rated as a Distinguished expert by MediFind in the treatment of Acquired Agranulocytosis. They are also highly rated in 9 other conditions, according to our data. Their top areas of expertise are Acquired Agranulocytosis, Febrile Neutropenia, Agranulocytosis, and Acute Kidney Failure.

What are the latest Acquired Agranulocytosis Clinical Trials?
A Pilot Study of Granulocyte Colony-Stimulating Factor Starting at 24 Hours vs 72 Hours in Pediatric Oncology Patients
Match to trials
Find the right clinical trials for you in under a minute
Get started
Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia According to the MASCC Score: a Prospective, Monocentric Observational Study (CALIF)
What are the Latest Advances for Acquired Agranulocytosis?
Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer.
PAC1 Receptor Mediates Electroacupuncture-Induced Neuro and Immune Protection During Cisplatin Chemotherapy.
Tired of the same old research?
Check Latest Advances
Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial.